NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,646 | +413.4% | 105 | +250.0% | 0.00% | – |
| Q2 2023 | $905 | +417.1% | 30 | +100.0% | 0.00% | – |
| Q1 2023 | $175 | +5733.3% | 15 | -87.7% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 122 | +67.1% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 73 | +58.7% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 46 | -28.1% | 0.00% | – |
| Q1 2022 | $3,000 | – | 64 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q1 2021 | $0 | – | 3 | -25.0% | 0.00% | – |
| Q4 2020 | $0 | – | 4 | -50.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 8 | -96.0% | 0.00% | – |
| Q2 2018 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |